UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000050258
Receipt number R000057225
Scientific Title Investigating the endophenotype of ADHD
Date of disclosure of the study information 2023/02/07
Last modified on 2023/02/07 17:57:34

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Investigating the endophenotype of ADHD

Acronym

Investigating the endophenotype of ADHD

Scientific Title

Investigating the endophenotype of ADHD

Scientific Title:Acronym

Investigating the endophenotype of ADHD

Region

Japan


Condition

Condition

Individuals with ADHD and their first-degree relatives

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Investigating the neurocognitive and neuroimaging endophenotype of ADHD

Basic objectives2

Others

Basic objectives -Others

Correlation between cognitive function and neuroimging marker

Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Common neuroimaging and neurocognitive marker of individuals with ADHD and their first-degree relatives

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Other

Interventions/Control_1

MRI data acquisition

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

16 years-old <=

Age-upper limit

65 years-old >=

Gender

Male and Female

Key inclusion criteria

Individuals with ADHD diagnosed by using DSM-5 and their first-degree relatives
Healthy individuals

Key exclusion criteria

Severe neurological disease, current and past history of alchol abuse, pregnancy, severe psysical disease

Target sample size

90


Research contact person

Name of lead principal investigator

1st name hirofumi
Middle name
Last name tomiyama

Organization

Kyushu University

Division name

Psychiatry

Zip code

812-8582

Address

3-1-1, Maidashi, Higashi-Ku, Fukuoka-shi

TEL

092-642-5640

Email

tomiyama.hirofumi.765@m.kyushu-u.ac.jp


Public contact

Name of contact person

1st name hirofumi
Middle name
Last name tomiyama

Organization

Kyushu University

Division name

Psychiatry

Zip code

812-8582

Address

3-1-1, Maidashi, Higashi-Ku, Fukuoka-shi

TEL

092-642-5640

Homepage URL


Email

bt.group@icloud.com


Sponsor or person

Institute

Kyushu-University

Institute

Department

Personal name



Funding Source

Organization

JSPS Kaken

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kyushu University Hospital Ethics Committee

Address

3-1-1, Maidashi, Higashi-Ku, Fukuoka-shi

Tel

092-641-1151

Email

byskenkyu@jimu.kyushu-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 02 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2023 Year 02 Month 07 Day

Date of IRB

2023 Year 02 Month 07 Day

Anticipated trial start date

2023 Year 02 Month 07 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 02 Month 07 Day

Last modified on

2023 Year 02 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000057225